Modern algorithms for statin therapy
HMG-CoA reductase inhibitors (statins) are a key class of drugs for the treatment and prevention of atherosclerosis and its complications. This class of drugs has become firmly established in Russian and international guidelines with a high level of evidence. However, the use of these drugs in pract...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2023-11-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/5594 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839576546230140928 |
|---|---|
| author | V. A. Susekov |
| author_facet | V. A. Susekov |
| author_sort | V. A. Susekov |
| collection | DOAJ |
| description | HMG-CoA reductase inhibitors (statins) are a key class of drugs for the treatment and prevention of atherosclerosis and its complications. This class of drugs has become firmly established in Russian and international guidelines with a high level of evidence. However, the use of these drugs in practice is not yet optimal. A significant proportion of patients at very high cardiovascular risk, taking initial doses of statins, do not achieve target levels of low-density lipoprotein cholesterol. The article is devoted to the analysis of international and Russian guidelines for statin monotherapy optimization, including their prescription in primary prevention using cardiovascular risk reclassification, coronary calcium score, carotid Doppler ultrasound and lipoprotein(a) levels. |
| format | Article |
| id | doaj-art-a099a7de6ba94e18b139a729bb956b8c |
| institution | Matheson Library |
| issn | 1560-4071 2618-7620 |
| language | Russian |
| publishDate | 2023-11-01 |
| publisher | «FIRMA «SILICEA» LLC |
| record_format | Article |
| series | Российский кардиологический журнал |
| spelling | doaj-art-a099a7de6ba94e18b139a729bb956b8c2025-08-04T13:00:31Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202023-11-01281010.15829/1560-4071-2023-55943912Modern algorithms for statin therapyV. A. Susekov0Russian Medical Academy of Continuous Professional EducationHMG-CoA reductase inhibitors (statins) are a key class of drugs for the treatment and prevention of atherosclerosis and its complications. This class of drugs has become firmly established in Russian and international guidelines with a high level of evidence. However, the use of these drugs in practice is not yet optimal. A significant proportion of patients at very high cardiovascular risk, taking initial doses of statins, do not achieve target levels of low-density lipoprotein cholesterol. The article is devoted to the analysis of international and Russian guidelines for statin monotherapy optimization, including their prescription in primary prevention using cardiovascular risk reclassification, coronary calcium score, carotid Doppler ultrasound and lipoprotein(a) levels.https://russjcardiol.elpub.ru/jour/article/view/5594hmg-coa reductase inhibitorsstatinsatorvastatinrosuvastatinguidelinesalgorithmscoronary calciumcarotid atherosclerosislipoprotein(a) |
| spellingShingle | V. A. Susekov Modern algorithms for statin therapy Российский кардиологический журнал hmg-coa reductase inhibitors statins atorvastatin rosuvastatin guidelines algorithms coronary calcium carotid atherosclerosis lipoprotein(a) |
| title | Modern algorithms for statin therapy |
| title_full | Modern algorithms for statin therapy |
| title_fullStr | Modern algorithms for statin therapy |
| title_full_unstemmed | Modern algorithms for statin therapy |
| title_short | Modern algorithms for statin therapy |
| title_sort | modern algorithms for statin therapy |
| topic | hmg-coa reductase inhibitors statins atorvastatin rosuvastatin guidelines algorithms coronary calcium carotid atherosclerosis lipoprotein(a) |
| url | https://russjcardiol.elpub.ru/jour/article/view/5594 |
| work_keys_str_mv | AT vasusekov modernalgorithmsforstatintherapy |